CTOs on the Move

BI Nutraceuticals

www.botanicals.com

 
BI Nutraceuticals is a solutions-based botanical manufacturer, custom contract manufacturer, and supplier to the Dietary Supplement, Food & Beverage, Pharmaceutical, Personal Care, and Pet Care Industries. We are the leading manufacturer of whole herb powders and teas, standardized and drug ratio extracts, vitamins, minerals, amino acids, custom blends, drum-to-hopper (D-T-H) formulations, and granular ingredients. BI Nutraceuticals is committed to providing top-quality ingredients, starting even before the raw material comes through the door with our in-depth industry knowledge and distinguished vendor qualification program. The moment we receive the material it undergoes BI`s Protexx HP™ Green Steam™ sterilization, our patented high pressure, low ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.botanicals.com
  • 2384 East Pacifica Place
    Rancho Dominguez, CA USA 90220
  • Phone: 310.669.2100

Executives

Name Title Contact Details

Similar Companies

Redco Group

Redco Group is a Stroudsburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

San Clemente Villas By The Sea

San Clemente Villas By The Sea is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Highline Wellness

Were on a mission to make a more pleasant world, one dose at a time. We provide natural, affordable, and effective CBD supplements to give everyone access to a happier, healthier, and more peaceful state of mind and body. Free 2-Day shipping, Lab Test...

Health Systems Management

Health Systems Management is a Tifton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.